ロード中...
Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors
Breast cancer is one of the leading causes of death worldwide, and therefore, new and improved approaches for the treatment of breast cancer are desperately needed. CtIP (RBBP8) is a multifunctional protein that is involved in various cellular functions, including transcription, DNA replication, DNA...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884948/ https://ncbi.nlm.nih.gov/pubmed/26713604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6715 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|